APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lomustine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Lomustine Market Analysis and Forecast 2026-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchLomustine Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Lomustine Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Lomustine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lomustine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Lomustine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Lomustine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Lomustine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Lomustine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Lomustine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Lomustine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Lomustine include Zhongfu Pharma, Nanjing Pharma, Bristol-Myers Squibb, Ther Dose, NextSource Pharma, Miracalus Pharma, Medicon Pharma and ACTIZA, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Lomustine, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lomustine, also provides the revenue of main regions and countries. Of the upcoming market potential for Lomustine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lomustine revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lomustine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Lomustine revenue, projected growth trends, production technology, application and end-user industry.

Lomustine Segment by Company

Zhongfu Pharma

Nanjing Pharma

Bristol-Myers Squibb

Ther Dose

NextSource Pharma

Miracalus Pharma

Medicon Pharma

ACTIZA

Lomustine Segment by Type

10mg/Tablet

40mg/Tablet

100mg/Tablet

Lomustine Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Lomustine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lomustine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lomustine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lomustine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Lomustine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Lomustine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lomustine revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lomustine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 10mg/Tablet Major Player Table 3. 40mg/Tablet Major Player Table 4. 100mg/Tablet Major Player Table 5. Global Lomustine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Pharmacies Major Player Table 7. Online Pharmacies Major Player Table 8. Retail Pharmacies Major Player Table 9. Lomustine Industry Trends Table 10. Lomustine Industry Drivers Table 11. Lomustine Industry Opportunities and Challenges Table 12. Lomustine Industry Restraints Table 13. Global Lomustine Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Lomustine Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Lomustine Market Share by Region (2021-2026) Table 16. Global Lomustine Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Lomustine Market Share by Region (2027-2032) Table 18. Global Lomustine Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Lomustine Revenue Market Share by Players (2021-2026) Table 20. Global Lomustine Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Lomustine Key Players Headquarters & Area Served Table 22. Global Lomustine Players, Product Type & Application Table 23. Global Lomustine Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Lomustine by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Lomustine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Lomustine Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Lomustine Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Lomustine Revenue Market Share by Type (2021-2026) Table 30. Global Lomustine Revenue Market Share by Type (2027-2032) Table 31. Global Lomustine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Lomustine Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Lomustine Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Lomustine Revenue Market Share by Application (2021-2026) Table 35. Global Lomustine Revenue Market Share by Application (2027-2032) Table 36. Zhongfu Pharma Company Information Table 37. Zhongfu Pharma Business Overview Table 38. Zhongfu Pharma Lomustine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Zhongfu Pharma Lomustine Product Portfolio Table 40. Zhongfu Pharma Recent Development Table 41. Nanjing Pharma Company Information Table 42. Nanjing Pharma Business Overview Table 43. Nanjing Pharma Lomustine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Nanjing Pharma Lomustine Product Portfolio Table 45. Nanjing Pharma Recent Development Table 46. Bristol-Myers Squibb Company Information Table 47. Bristol-Myers Squibb Business Overview Table 48. Bristol-Myers Squibb Lomustine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Bristol-Myers Squibb Lomustine Product Portfolio Table 50. Bristol-Myers Squibb Recent Development Table 51. Ther Dose Company Information Table 52. Ther Dose Business Overview Table 53. Ther Dose Lomustine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Ther Dose Lomustine Product Portfolio Table 55. Ther Dose Recent Development Table 56. NextSource Pharma Company Information Table 57. NextSource Pharma Business Overview Table 58. NextSource Pharma Lomustine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. NextSource Pharma Lomustine Product Portfolio Table 60. NextSource Pharma Recent Development Table 61. Miracalus Pharma Company Information Table 62. Miracalus Pharma Business Overview Table 63. Miracalus Pharma Lomustine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Miracalus Pharma Lomustine Product Portfolio Table 65. Miracalus Pharma Recent Development Table 66. Medicon Pharma Company Information Table 67. Medicon Pharma Business Overview Table 68. Medicon Pharma Lomustine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Medicon Pharma Lomustine Product Portfolio Table 70. Medicon Pharma Recent Development Table 71. ACTIZA Company Information Table 72. ACTIZA Business Overview Table 73. ACTIZA Lomustine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. ACTIZA Lomustine Product Portfolio Table 75. ACTIZA Recent Development Table 76. North America Lomustine Revenue by Type (2021-2026) & (US$ Million) Table 77. North America Lomustine Revenue by Type (2027-2032) & (US$ Million) Table 78. North America Lomustine Revenue by Application (2021-2026) & (US$ Million) Table 79. North America Lomustine Revenue by Application (2027-2032) & (US$ Million) Table 80. North America Lomustine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. North America Lomustine Revenue by Country (2021-2026) & (US$ Million) Table 82. North America Lomustine Revenue by Country (US$ Million) & (2027-2032) Table 83. Europe Lomustine Revenue by Type (2021-2026) & (US$ Million) Table 84. Europe Lomustine Revenue by Type (2027-2032) & (US$ Million) Table 85. Europe Lomustine Revenue by Application (2021-2026) & (US$ Million) Table 86. Europe Lomustine Revenue by Application (2027-2032) & (US$ Million) Table 87. Europe Lomustine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. Europe Lomustine Revenue by Country (2021-2026) & (US$ Million) Table 89. Europe Lomustine Revenue by Country (US$ Million) & (2027-2032) Table 90. China Lomustine Revenue by Type (2021-2026) & (US$ Million) Table 91. China Lomustine Revenue by Type (2027-2032) & (US$ Million) Table 92. China Lomustine Revenue by Application (2021-2026) & (US$ Million) Table 93. China Lomustine Revenue by Application (2027-2032) & (US$ Million) Table 94. Asia Lomustine Revenue by Type (2021-2026) & (US$ Million) Table 95. Asia Lomustine Revenue by Type (2027-2032) & (US$ Million) Table 96. Asia Lomustine Revenue by Application (2021-2026) & (US$ Million) Table 97. Asia Lomustine Revenue by Application (2027-2032) & (US$ Million) Table 98. Asia Lomustine Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Asia Lomustine Revenue by Region (US$ Million) & (2021-2026) Table 100. Asia Lomustine Revenue by Region (US$ Million) & (2027-2032) Table 101. SAMEA Lomustine Revenue by Type (2021-2026) & (US$ Million) Table 102. SAMEA Lomustine Revenue by Type (2027-2032) & (US$ Million) Table 103. SAMEA Lomustine Revenue by Application (2021-2026) & (US$ Million) Table 104. SAMEA Lomustine Revenue by Application (2027-2032) & (US$ Million) Table 105. SAMEA Lomustine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. SAMEA Lomustine Revenue by Country (2021-2026) & (US$ Million) Table 107. SAMEA Lomustine Revenue by Country (US$ Million) & (2027-2032) Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Lomustine Image Figure 2. Global Lomustine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lomustine Market Size Share 2021 VS 2025 VS 2032 Figure 4. 10mg/Tablet Image Figure 5. 40mg/Tablet Image Figure 6. 100mg/Tablet Image Figure 7. Global Lomustine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Lomustine Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Pharmacies Image Figure 10. Online Pharmacies Image Figure 11. Retail Pharmacies Image Figure 12. Global Lomustine Market Size (US$ Million) & (2021-2032) Figure 13. Global Lomustine Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Lomustine Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Lomustine Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Lomustine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Lomustine Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Lomustine Revenue Market Share by Type (2021-2032) Figure 20. Global Lomustine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Lomustine Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Lomustine Revenue Market Share by Application (2021-2032) Figure 23. North America Lomustine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Lomustine Revenue Share by Type (2021-2032) Figure 25. North America Lomustine Revenue Share by Application (2021-2032) Figure 26. North America Lomustine Revenue Share by Country (2021-2032) Figure 27. United States Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Lomustine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Lomustine Revenue Share by Type (2021-2032) Figure 32. Europe Lomustine Revenue Share by Application (2021-2032) Figure 33. Europe Lomustine Revenue Share by Country (2021-2032) Figure 34. Germany Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Lomustine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Lomustine Revenue Share by Type (2021-2032) Figure 44. China Lomustine Revenue Share by Application (2021-2032) Figure 45. Asia Lomustine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Lomustine Revenue Share by Type (2021-2032) Figure 47. Asia Lomustine Revenue Share by Application (2021-2032) Figure 48. Asia Lomustine Revenue Share by Region (2021-2032) Figure 49. Japan Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Lomustine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Lomustine Revenue Share by Type (2021-2032) Figure 57. SAMEA Lomustine Revenue Share by Application (2021-2032) Figure 58. SAMEA Lomustine Revenue Share by Country (2021-2032) Figure 59. Brazil Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Lomustine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg/Tablet
  • 40mg/Tablet
  • 100mg/Tablet
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Zhongfu Pharma
  • Nanjing Pharma
  • Bristol-Myers Squibb
  • Ther Dose
  • NextSource Pharma
  • Miracalus Pharma
  • Medicon Pharma
  • ACTIZA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lomustine Market by Type
  3. 1.2.1 Global Lomustine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 10mg/Tablet
  5. 1.2.3 40mg/Tablet
  6. 1.2.4 100mg/Tablet
  7. 1.3 Lomustine Market by Application
  8. 1.3.1 Global Lomustine Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital Pharmacies
  10. 1.3.3 Online Pharmacies
  11. 1.3.4 Retail Pharmacies
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Lomustine Market Dynamics
  1. 2.1 Lomustine Industry Trends
  2. 2.2 Lomustine Industry Drivers
  3. 2.3 Lomustine Industry Opportunities and Challenges
  4. 2.4 Lomustine Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Lomustine Market Perspective (2021-2032)
  2. 3.2 Global Lomustine Growth Trends by Region
  3. 3.2.1 Global Lomustine Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lomustine Market Size by Region (2021-2026)
  5. 3.2.3 Global Lomustine Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Lomustine Revenue by Players
  2. 4.1.1 Global Lomustine Revenue by Players (2021-2026)
  3. 4.1.2 Global Lomustine Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Lomustine Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lomustine Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Lomustine Key Players Headquarters & Area Served
  7. 4.4 Global Lomustine Players, Product Type & Application
  8. 4.5 Global Lomustine Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Lomustine Market CR5 and HHI
  11. 4.6.3 2025 Lomustine Tier 1, Tier 2, and Tier 3
5 Lomustine Market Size by Type
  1. 5.1 Global Lomustine Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Lomustine Revenue by Type (2021-2032)
  3. 5.3 Global Lomustine Revenue Market Share by Type (2021-2032)
6 Lomustine Market Size by Application
  1. 6.1 Global Lomustine Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Lomustine Revenue by Application (2021-2032)
  3. 6.3 Global Lomustine Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Zhongfu Pharma
  2. 7.1.1 Zhongfu Pharma Company Information
  3. 7.1.2 Zhongfu Pharma Business Overview
  4. 7.1.3 Zhongfu Pharma Lomustine Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Zhongfu Pharma Lomustine Product Portfolio
  6. 7.1.5 Zhongfu Pharma Recent Developments
  7. 7.2 Nanjing Pharma
  8. 7.2.1 Nanjing Pharma Company Information
  9. 7.2.2 Nanjing Pharma Business Overview
  10. 7.2.3 Nanjing Pharma Lomustine Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Nanjing Pharma Lomustine Product Portfolio
  12. 7.2.5 Nanjing Pharma Recent Developments
  13. 7.3 Bristol-Myers Squibb
  14. 7.3.1 Bristol-Myers Squibb Company Information
  15. 7.3.2 Bristol-Myers Squibb Business Overview
  16. 7.3.3 Bristol-Myers Squibb Lomustine Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Bristol-Myers Squibb Lomustine Product Portfolio
  18. 7.3.5 Bristol-Myers Squibb Recent Developments
  19. 7.4 Ther Dose
  20. 7.4.1 Ther Dose Company Information
  21. 7.4.2 Ther Dose Business Overview
  22. 7.4.3 Ther Dose Lomustine Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Ther Dose Lomustine Product Portfolio
  24. 7.4.5 Ther Dose Recent Developments
  25. 7.5 NextSource Pharma
  26. 7.5.1 NextSource Pharma Company Information
  27. 7.5.2 NextSource Pharma Business Overview
  28. 7.5.3 NextSource Pharma Lomustine Revenue and Gross Margin (2021-2026)
  29. 7.5.4 NextSource Pharma Lomustine Product Portfolio
  30. 7.5.5 NextSource Pharma Recent Developments
  31. 7.6 Miracalus Pharma
  32. 7.6.1 Miracalus Pharma Company Information
  33. 7.6.2 Miracalus Pharma Business Overview
  34. 7.6.3 Miracalus Pharma Lomustine Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Miracalus Pharma Lomustine Product Portfolio
  36. 7.6.5 Miracalus Pharma Recent Developments
  37. 7.7 Medicon Pharma
  38. 7.7.1 Medicon Pharma Company Information
  39. 7.7.2 Medicon Pharma Business Overview
  40. 7.7.3 Medicon Pharma Lomustine Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Medicon Pharma Lomustine Product Portfolio
  42. 7.7.5 Medicon Pharma Recent Developments
  43. 7.8 ACTIZA
  44. 7.8.1 ACTIZA Company Information
  45. 7.8.2 ACTIZA Business Overview
  46. 7.8.3 ACTIZA Lomustine Revenue and Gross Margin (2021-2026)
  47. 7.8.4 ACTIZA Lomustine Product Portfolio
  48. 7.8.5 ACTIZA Recent Developments
8 North America
  1. 8.1 North America Lomustine Revenue (2021-2032)
  2. 8.2 North America Lomustine Revenue by Type (2021-2032)
  3. 8.2.1 North America Lomustine Revenue by Type (2021-2026)
  4. 8.2.2 North America Lomustine Revenue by Type (2027-2032)
  5. 8.3 North America Lomustine Revenue Share by Type (2021-2032)
  6. 8.4 North America Lomustine Revenue by Application (2021-2032)
  7. 8.4.1 North America Lomustine Revenue by Application (2021-2026)
  8. 8.4.2 North America Lomustine Revenue by Application (2027-2032)
  9. 8.5 North America Lomustine Revenue Share by Application (2021-2032)
  10. 8.6 North America Lomustine Revenue by Country
  11. 8.6.1 North America Lomustine Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Lomustine Revenue by Country (2021-2026)
  13. 8.6.3 North America Lomustine Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Lomustine Revenue (2021-2032)
  2. 9.2 Europe Lomustine Revenue by Type (2021-2032)
  3. 9.2.1 Europe Lomustine Revenue by Type (2021-2026)
  4. 9.2.2 Europe Lomustine Revenue by Type (2027-2032)
  5. 9.3 Europe Lomustine Revenue Share by Type (2021-2032)
  6. 9.4 Europe Lomustine Revenue by Application (2021-2032)
  7. 9.4.1 Europe Lomustine Revenue by Application (2021-2026)
  8. 9.4.2 Europe Lomustine Revenue by Application (2027-2032)
  9. 9.5 Europe Lomustine Revenue Share by Application (2021-2032)
  10. 9.6 Europe Lomustine Revenue by Country
  11. 9.6.1 Europe Lomustine Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Lomustine Revenue by Country (2021-2026)
  13. 9.6.3 Europe Lomustine Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Lomustine Revenue (2021-2032)
  2. 10.2 China Lomustine Revenue by Type (2021-2032)
  3. 10.2.1 China Lomustine Revenue by Type (2021-2026)
  4. 10.2.2 China Lomustine Revenue by Type (2027-2032)
  5. 10.3 China Lomustine Revenue Share by Type (2021-2032)
  6. 10.4 China Lomustine Revenue by Application (2021-2032)
  7. 10.4.1 China Lomustine Revenue by Application (2021-2026)
  8. 10.4.2 China Lomustine Revenue by Application (2027-2032)
  9. 10.5 China Lomustine Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lomustine Revenue (2021-2032)
  2. 11.2 Asia Lomustine Revenue by Type (2021-2032)
  3. 11.2.1 Asia Lomustine Revenue by Type (2021-2026)
  4. 11.2.2 Asia Lomustine Revenue by Type (2027-2032)
  5. 11.3 Asia Lomustine Revenue Share by Type (2021-2032)
  6. 11.4 Asia Lomustine Revenue by Application (2021-2032)
  7. 11.4.1 Asia Lomustine Revenue by Application (2021-2026)
  8. 11.4.2 Asia Lomustine Revenue by Application (2027-2032)
  9. 11.5 Asia Lomustine Revenue Share by Application (2021-2032)
  10. 11.6 Asia Lomustine Revenue by Country
  11. 11.6.1 Asia Lomustine Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Lomustine Revenue by Country (2021-2026)
  13. 11.6.3 Asia Lomustine Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lomustine Revenue (2021-2032)
  2. 12.2 SAMEA Lomustine Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Lomustine Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Lomustine Revenue by Type (2027-2032)
  5. 12.3 SAMEA Lomustine Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Lomustine Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Lomustine Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Lomustine Revenue by Application (2027-2032)
  9. 12.5 SAMEA Lomustine Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Lomustine Revenue by Country
  11. 12.6.1 SAMEA Lomustine Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Lomustine Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Lomustine Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst